Chelsea Therapeutics International, Ltd.
SEC CIK 1333763 · CHTP.OB · last insider filing 2014-06-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Stoll Roger G PHD | Director | filed 2008–2014 |
| Weiser Michael | Director | filed 2006–2014 |
| Clemens Kevan | Director | filed 2006–2014 |
| Rueckert William Dodge | Director | filed 2009–2014 |
| Schwieterman William D | Director · Chief Medical Officer | filed 2008–2014 |
| Oliveto Joseph | Director · Vice President of Operations | filed 2008–2014 |
| LAU Johnson YIU NAM | Director | filed 2006–2012 |
| Hardman Norman PHD | Director | filed 2008–2012 |
| Pedder Simon | Director · Chief Executive Officer | filed 2006–2012 |
| Herskowitz Neil | Director | filed 2006–2008 |
| Stein Jason | Director | filed 2006–2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Riehle J Nick | Chief Financial Officer | filed 2006–2014 |
| Hewitt L Arthur | Vice Pres. of Drug Development | filed 2006–2014 |
| Schmidt Keith | Vice Pres. Marketing and Sales | filed 2007–2014 |
| Roberts Michael J | VP, Business Development | filed 2010–2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.